Please login to the form below

Not currently logged in
Email:
Password:

tremelimumab,

This page shows the latest tremelimumab, news and features for those working in and with pharma, biotech and healthcare.

Merck CFO: we’re not only about Keytruda

Merck CFO: we’re not only about Keytruda

Meanwhile, AZ has just reported positive top-line results with Imfinzi (durvalumab) plus experimental CTLA4 tremelimumab in the  POSEIDON study.

Latest news

More from news
Approximately 5 fully matching, plus 52 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma...
WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....

Infographics